Literature DB >> 27371672

The Epilepsy Spectrum: Targeting Future Research Challenges.

Gregory L Holmes1, Jeffrey L Noebels2.   

Abstract

There have been tremendous recent advances in our understanding of the biological underpinnings of epilepsy and associated comorbidities that justify its representation as a spectrum disorder. Advances in genetics, electrophysiology, and neuroimaging have greatly improved our ability to differentiate, diagnose, and treat individuals with epilepsy. However, we have made little overall progress in preventing epilepsy, and the number of patients who are cured remains small. Likewise, the comorbidities of epilepsy are often underdiagnosed or not adequately treated. In this article, we suggest a few areas in which additional research will likely pay big dividends for patients and their families.
Copyright © 2016 Cold Spring Harbor Laboratory Press; all rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27371672      PMCID: PMC4930917          DOI: 10.1101/cshperspect.a028043

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Med        ISSN: 2157-1422            Impact factor:   6.915


  61 in total

1.  Early development of neuronal activity in the primate hippocampus in utero.

Authors:  R Khazipov; M Esclapez; O Caillard; C Bernard; I Khalilov; R Tyzio; J Hirsch; V Dzhala; B Berger; Y Ben-Ari
Journal:  J Neurosci       Date:  2001-12-15       Impact factor: 6.167

Review 2.  Prospects for imaging-related biomarkers of human epileptogenesis: a critical review.

Authors:  William A Gomes; Shlomo Shinnar
Journal:  Biomark Med       Date:  2011-10       Impact factor: 2.851

Review 3.  Epilepsy: new genes, new technologies, new insights.

Authors:  Byung In Lee; Kyoung Heo
Journal:  Lancet Neurol       Date:  2014-01       Impact factor: 44.182

Review 4.  Blood-brain barrier dysfunction, seizures and epilepsy.

Authors:  E A van Vliet; E Aronica; J A Gorter
Journal:  Semin Cell Dev Biol       Date:  2014-11-06       Impact factor: 7.727

Review 5.  Epilepsy biomarkers.

Authors:  Jerome Engel; Asla Pitkänen; Jeffrey A Loeb; F Edward Dudek; Edward H Bertram; Andrew J Cole; Solomon L Moshé; Samuel Wiebe; Frances E Jensen; Istvan Mody; Astrid Nehlig; Annamaria Vezzani
Journal:  Epilepsia       Date:  2013-08       Impact factor: 5.864

6.  Differential ontogenic development of three receptors comprising the NMDA receptor/channel complex in the rat hippocampus.

Authors:  J W McDonald; M V Johnston; A B Young
Journal:  Exp Neurol       Date:  1990-12       Impact factor: 5.330

Review 7.  The neurobiology of cognitive disorders in temporal lobe epilepsy.

Authors:  Brian Bell; Jack J Lin; Michael Seidenberg; Bruce Hermann
Journal:  Nat Rev Neurol       Date:  2011-02-08       Impact factor: 42.937

8.  Blood-brain barrier leakage may lead to progression of temporal lobe epilepsy.

Authors:  E A van Vliet; S da Costa Araújo; S Redeker; R van Schaik; E Aronica; J A Gorter
Journal:  Brain       Date:  2006-11-22       Impact factor: 13.501

9.  Bumetanide inhibits rapid kindling in neonatal rats.

Authors:  Andréy Mazarati; Don Shin; Raman Sankar
Journal:  Epilepsia       Date:  2009-02-26       Impact factor: 5.864

10.  Bumetanide enhances phenobarbital efficacy in a neonatal seizure model.

Authors:  Volodymyr I Dzhala; Audrey C Brumback; Kevin J Staley
Journal:  Ann Neurol       Date:  2008-02       Impact factor: 10.422

View more
  10 in total

Review 1.  The Impact of Next-Generation Sequencing on the Diagnosis and Treatment of Epilepsy in Paediatric Patients.

Authors:  Davide Mei; Elena Parrini; Carla Marini; Renzo Guerrini
Journal:  Mol Diagn Ther       Date:  2017-08       Impact factor: 4.074

Review 2.  Monoaminergic Mechanisms in Epilepsy May Offer Innovative Therapeutic Opportunity for Monoaminergic Multi-Target Drugs.

Authors:  Dubravka Svob Strac; Nela Pivac; Ilse J Smolders; Wieslawa A Fogel; Philippe De Deurwaerdere; Giuseppe Di Giovanni
Journal:  Front Neurosci       Date:  2016-11-10       Impact factor: 4.677

3.  Optical mapping of neuronal activity during seizures in zebrafish.

Authors:  L Turrini; C Fornetto; G Marchetto; M C Müllenbroich; N Tiso; A Vettori; F Resta; A Masi; G Mannaioni; F S Pavone; F Vanzi
Journal:  Sci Rep       Date:  2017-06-08       Impact factor: 4.379

4.  Home-cage monitoring ascertains signatures of ictal and interictal behavior in mouse models of generalized seizures.

Authors:  Miranda J Jankovic; Paarth P Kapadia; Vaishnav Krishnan
Journal:  PLoS One       Date:  2019-11-07       Impact factor: 3.240

5.  Length Polymorphism and Methylation Status of UPS29 Minisatellite of the ACAP3 Gene as Molecular Biomarker of Epilepsy. Sex Differences in Seizure Types and Symptoms.

Authors:  Irina O Suchkova; Elena V Borisova; Eugene L Patkin
Journal:  Int J Mol Sci       Date:  2020-12-02       Impact factor: 5.923

6.  The polymicrogyria-associated GPR56 promoter preferentially drives gene expression in developing GABAergic neurons in common marmosets.

Authors:  Ayako Y Murayama; Ken-Ichiro Kuwako; Junko Okahara; Byoung-Il Bae; Misako Okuno; Hiromi Mashiko; Tomomi Shimogori; Christopher A Walsh; Erika Sasaki; Hideyuki Okano
Journal:  Sci Rep       Date:  2020-12-09       Impact factor: 4.379

Review 7.  From Physiology to Pathology of Cortico-Thalamo-Cortical Oscillations: Astroglia as a Target for Further Research.

Authors:  Davide Gobbo; Anja Scheller; Frank Kirchhoff
Journal:  Front Neurol       Date:  2021-06-09       Impact factor: 4.003

Review 8.  Progress of Induced Pluripotent Stem Cell Technologies to Understand Genetic Epilepsy.

Authors:  Bruno Sterlini; Floriana Fruscione; Simona Baldassari; Fabio Benfenati; Federico Zara; Anna Corradi
Journal:  Int J Mol Sci       Date:  2020-01-12       Impact factor: 5.923

Review 9.  Clinical and experimental insight into pathophysiology, comorbidity and therapy of absence seizures.

Authors:  Vincenzo Crunelli; Magor L Lőrincz; Cian McCafferty; Régis C Lambert; Nathalie Leresche; Giuseppe Di Giovanni; François David
Journal:  Brain       Date:  2020-08-01       Impact factor: 13.501

Review 10.  Human pluripotent stem cell-derived brain organoids as in vitro models for studying neural disorders and cancer.

Authors:  Juan Luo; Peng Li
Journal:  Cell Biosci       Date:  2021-05-28       Impact factor: 7.133

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.